Paula Soteropoulos's Insider Trades & SAST Disclosures
Paula Soteropoulos's most recent trade in Rallybio Corp was a trade of 28,500 Option (Right to Buy) done . Disclosure was reported to the exchange on May 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Paula Soteropoulos.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rallybio Corp | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 28,500 | 28,500 | - | - | Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Sale of securities on an exchange or to another person at price $ 5.14 per share. | 13 Jun 2024 | 2,220 | 20,203 (0%) | 0% | 5.1 | 11,411 | Ordinary Shares |
| Dianthus Therapeutics Inc | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Rallybio Corp | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 16,500 | 16,500 | - | - | Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 17,060 | 17,060 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 8,700 | 24,698 (0%) | 0% | 0 | Ordinary Shares | |
| uniQure N.V. | Paula Soteropoulos | Director | Sale of securities on an exchange or to another person at price $ 18.99 per share. | 13 Jun 2023 | 2,275 | 22,423 (0%) | 0% | 19.0 | 43,202 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Sale of securities on an exchange or to another person at price $ 19.97 per share. | 27 Feb 2023 | 384 | 15,998 (0%) | 0% | 20.0 | 7,668 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.37 per share. | 18 Jan 2023 | 6,000 | 22,382 (0%) | 0% | 5.4 | 32,220 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2023 | 6,000 | 2,000 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Sale of securities on an exchange or to another person at price $ 22.59 per share. | 18 Jan 2023 | 6,000 | 16,382 (0%) | 0% | 22.6 | 135,540 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 3,800 | 0 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Sale of securities on an exchange or to another person at price $ 23.43 per share. | 13 Dec 2022 | 3,800 | 16,382 (0%) | 0% | 23.4 | 89,034 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 3,800 | 20,182 (0%) | 0% | - | Ordinary Shares | |
| uniQure N.V. | Paula Soteropoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.37 per share. | 13 Dec 2022 | 3,000 | 19,382 (0%) | 0% | 5.4 | 16,110 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 3,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Sale of securities on an exchange or to another person at price $ 23.45 per share. | 13 Dec 2022 | 3,000 | 16,382 (0%) | 0% | 23.5 | 70,350 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2022 | 6,200 | 22,582 (0%) | 0% | - | Ordinary Shares | |
| uniQure N.V. | Paula Soteropoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2022 | 6,200 | 3,800 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Sale of securities on an exchange or to another person at price $ 25.38 per share. | 29 Nov 2022 | 6,200 | 16,382 (0%) | 0% | 25.4 | 157,356 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 17,810 | 17,810 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,080 | 16,382 (0%) | 0% | 0 | Ordinary Shares | |
| Rallybio Corp | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 13,440 | 13,440 | - | - | Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Sale of securities on an exchange or to another person at price $ 16.87 per share. | 28 Feb 2022 | 596 | 7,302 (0%) | 0% | 16.9 | 10,055 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,645 | 2,645 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 1,534 | 7,898 (0%) | 0% | 0 | Ordinary Shares | |
| Rallybio Corp | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 5,369 | 5,369 | - | - | Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Sale of securities on an exchange or to another person at price $ 37.60 per share. | 02 Mar 2021 | 504 | 6,364 (0%) | 0% | 37.6 | 18,950 | Ordinary Shares |
| uniQure N.V. | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 4,107 | 4,107 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 2,382 | 6,868 (0%) | 0% | 0 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges